Migration and function of cutaneous B cells

皮肤 B 细胞的迁移和功能

• 批准号: 9213284
• 负责人: Gudrun Philomena Debes
• 金额: $ 31.2万
• 依托单位: THOMAS JEFFERSON UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-01-05 至 2021-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9213284
• 关键词: Affect; Anti-Inflammatory Agents; Anti-inflammatory; B-Lymphocyte Subsets; B-Lymphocytes; Blood; Cannulations; Cells; Characteristics; Chronic; Clinical; Contact Dermatitis; Cutaneous; Cytometry; Data; Defect; Development; Disease; Environment; Genetic Models; Homing; Human; Immune; Immune Targeting; Immune system; Impairment; Individual; Infection; Infectious Skin Diseases; Inflammation; Inflammatory; Integrin alpha4; Integrin alpha4beta1; Integrins; Interleukin-10; Knowledge; Lymph; Mediating; Modeling; Mus; Organ; Pathology; Pathway interactions; Patients; Pattern; Peripheral; Phase; Property; Psoriasis; Recruitment Activity; Regulation; Role; Route; Sheep; Skin; Skin Cancer; Specimen; T-Lymphocyte; Testing; Therapeutic; Therapeutic immunosuppression; Translating; Tropism; Work; experimental study; migration; mouse model; natalizumab; novel; novel strategies; novel therapeutic intervention; novel therapeutics; receptor; response; skin disorder; tool; trafficking; tumor

SUMMARY The skin is a critical barrier organ and the frequent target of immune-mediated pathologies, such as psoriasis. Despite a newly identified key role of B cells in pro-and anti-inflammatory cutaneous responses, little is known about skin-associated B cells. We newly discovered that IL-10+ regulatory B cells (Bregs) with known potential to suppress T cell-driven skin inflammation preferentially migrate into the inflamed skin of mice. We also identified IL-10+ Bregs in human skin, validating human relevance of our findings in mice. Our studies show that Breg trafficking into skin is independent of canonical skin-homing receptors and instead requires α4β1- integrin, which was constitutively expressed in an activated state on Bregs. The data suggest that Bregs are efficient skin-targeting cells and point to a so far unexplored anti-inflammatory pathway that may translate into novel therapeutic approaches for inflammatory skin diseases. We hypothesize that skin Bregs fill a specialized niche in the regulation of skin inflammation and that they can be targeted through their migration. We also propose that impaired Breg recruitment into skin exacerbates skin inflammation. Human psoriasis is associated with a dearth of cutaneous IL-10 and clinically responsive to IL-10 therapy. B cell depletion induces psoriasis in some individuals, supporting a protective role of B cells in this disease. Therefore, psoriasiform inflammation is likely affected by reduced recruitment of IL-10+ Bregs into skin and a main focus of our studies. Under Aim 1 we will reveal the conditions that drive Breg accumulation in skin and define the IL-10-dependent and -independent regulatory properties of skin Bregs during inflammation. Under Aim 2 we will both determine the trafficking receptor signatures of human skin B cell subsets, including Bregs, as well as use a model of afferent lymph cannulation in sheep to reveal the relative skin tropism of skin B cell subsets. The results will allow us to manipulate the localization of anti-inflammatory B cells therapeutically and to recognize dysregulation of their migration. Finally, under Aim 3, we will block IL-10+ Breg migration into skin in a model of psoriasiform inflammation, thereby elucidating whether Breg trafficking into skin is essential to limiting inflammation. We will also evaluate human skin affected by psoriasis for a potential lack of recruited Bregs. This will determine whether skin recruitment and localization of Bregs are essential for the suppression of psoriasiform inflammation. In conclusion, this proposal will reveal the migratory routes, employed trafficking receptors, and anti-inflammatory functions of newly identified cutaneous IL-10+ B cells. Given the wide association of B cells with a large number of skin pathologies, ranging from inflammation, infection and skin cancers and the dearth of knowledge about skin B cells, our work will close a significant knowledge gap with great potential to exploit the gained knowledge for therapeutic purposes

总结